Reactogenicity and Safety of Two Doses of GlaxoSmithKline (GSK) Biologicals Oral Live Attenuated Liquid Human Rotavirus (HRV) Vaccine 444563, in Healthy Infants.
Phase of Trial: Phase I
Latest Information Update: 20 May 2017
At a glance
- Drugs Rotavirus vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- 28 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2011 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 09 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.